Quotes with Resistance & Support
Market Information

Intraday calls for 01-04-10

Markets likely to see a higher opening. Support for nifty is at 5250 and resistance at 5320. If markets show weakness later during the day, sell: Dishman Pharmaceuticals and Chemicals Ltd – (exit positions at 216.50) …

Read More..

read more

Buy Dishman Pharma, target of Rs 230: Hem Securities

Posted on: May 30th 2009 in Brokerage Recommendations.

Hem Securities has recommended a buy rating on Dishman Pharmaceuticals & Chemicals with price target of Rs 230 in its May 28, 2009 research report. “The company is a leader in CRAM business amongst the largest Indian pharmaceutical companies. Moreover, in global crisis and wea…

Read More..

read more

Buy Dishman Pharma, target Rs 221: Reliance Money

Posted on: May 28th 2009 in Brokerage Recommendations.

Reliance Money has maintained its buy rating on Dishman Pharmaceuticals & Chemicals with target of Rs 221 in its May 28, 2009 research report. “Dishman Pharmaceuticals & Chemicals Ltd (Dishman) reported better than expec…

Read More..

read more

Dishman Pharma an outperformer: Karvy

Posted on: May 28th 2009 in Brokerage Recommendations.

Karvy Stock Broking has downgraded its rating on Dishman Pharmaceuticals & Chemicals from buy to an outperformer with a target price of Rs 220 in its May 28,2009 research report. “The management has given the guidance of 15% …

Read More..

read more

Intraday calls for 27-05-09

Markets likley to see a gap up opening. Buy Kalindee Rail Nirman at 152, target: 160. Stoploss: 148 Buy Dishman Pharma at 173, target: 183. Stoploss: 169 …

Read More..

read more

The Southward journey may continue

Posted on: May 25th 2009 in Market Outlook.

The outlook continues to remain a bit cautious for the coming days as Tuesday saw markets taking a breather. In addition, the global economic slowdown, sluggish local economy, ballooning fiscal deficit continue to remain as headwinds. Markets witnessed a sharp sell off on Tuesday ahead o…

Read More..

read more

Buy Dishman Pharma, target of Rs 185: Reliance Money

Posted on: April 7th 2009 in Brokerage Recommendations.

Reliance Money has maintained its buy rating on Dishman Pharmaceuticals & Chemicals with a target price of Rs 185 in its April 6, 2009 research report. “Dishman Pharmaceuticals & Chemicals Ltd (Dishman), is setting up a Rs 350 million US FDA and MHRA approvable drug formul…

Read More..

read more